Atellica CH Acetaminophen 2 (ACTM)
Colorimetry, Acetaminophen. 510(k) K261364, from Siemens Healthcare Diagnostics, Inc. (Tarrytown, NY). Product code LDP, class 2.
As of Nov 20, 2026, K261364 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Jul 24, 2026 after 88 days, with no recalls tied to it in FDA's recall database.
- Review time: 88 days
- Recalls: 0
The Atellica CH Acetaminophen 2 (ACTM) assay is for in vitro diagnostic use in the quantitative determination of acetaminophen in human serum and plasma (K2 EDTA, lithium heparin, sodium heparin) using the Atellica CH Analyzer. Measurements obtained by this device are used in the diagnosis and treatment of acetaminophen overdose.
- Emit Tox Acetaminophen Assay, Model 7A319UL; Emit Tox Ecetaminophen Calibrators, Model 7A409ULK002974 · Dade Behring, Inc. · Oct 11, 2000
- AcetaminophenK202644 · Sekisui Diagnostics P.E.I., Inc. · Feb 18, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 27, 2026
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3030
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files